Barrett's esophagus: What do we need to know?

Area of Science:

• Gastroenterology
• Oncology
• Pathology

Background:

• Barrett's esophagus (BE) is a premalignant condition where esophageal squamous epithelium is replaced by metaplastic columnar epithelium.
• BE is a significant risk factor for esophageal adenocarcinoma, a type of cancer.
• Gastroesophageal reflux disease (GERD) is a primary risk factor, especially in individuals with additional risk factors.

Purpose of the Study:

• To provide a comprehensive review of Barrett's esophagus.
• To detail the pathophysiology, diagnostic methods, surveillance strategies, and management options for BE.
• To inform clinicians on screening high-risk GERD patients.

Main Methods:

• Literature review of pathophysiology, diagnosis, surveillance, and management of BE.
• Analysis of risk factors for BE development and progression.
• Summary of current guidelines for endoscopic screening and surveillance.

Main Results:

• BE is characterized by metaplasia in the distal esophagus, increasing cancer risk.
• Risk factors for BE screening include GERD, Caucasian race, male gender, age > 50, tobacco use, and central obesity.
• Surveillance involves esophagogastroduodenoscopy and regular endoscopic monitoring (every 3-5 years) for dysplasia.

Conclusions:

• Early detection and management of BE are critical to prevent esophageal adenocarcinoma.
• Endoscopic surveillance is recommended for patients with BE, with treatment for dysplasia.
• This review synthesizes current knowledge for effective clinical practice regarding BE.